Rock Springs Capital Management’s CONMED CNMD Stock Holding History

Rock Springs Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-205,000	Closed	-$27.9M	–	125
2023 Q2	$27.9M	Hold	205,000	–	–	0.66%	49
2023 Q1	$21.3M	Hold	205,000	–	–	0.51%	55
2022 Q4	$18.2M	Sell	205,000 -28,000	-12%	-$2.32M	0.44%	61
2022 Q3	$18.7M	Buy	233,000 +10,000	+4%	+$943K	0.48%	58
2022 Q2	$21.4M	Buy	223,000 +20,500	+10%	+$2.46M	0.62%	48
2022 Q1	$30.1M	Hold	202,500	–	–	0.76%	44
2021 Q4	$28.7M	Buy	202,500 +40,000	+25%	+$5.67M	0.66%	52
2021 Q3	$21.3M	Hold	162,500	–	–	0.45%	70
2021 Q2	$22.3M	Buy	162,500 +77,415	+91%	+$10.6M	0.44%	68
2021 Q1	$11.1M	Buy	85,085 +7,085	+9%	+$853K	0.24%	104
2020 Q4	$8.74M	Sell	78,000 -102,000	-57%	-$9.66M	0.19%	117
2020 Q3	$14.2M	Hold	180,000	–	–	0.36%	83
2020 Q2	$13M	Hold	180,000	–	–	0.36%	91
2020 Q1	$10.3M	Buy	+180,000	New	+$16.6M	0.43%	76

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Rock Springs Capital Management's CNMD Position: Q3 2023 in Review

Rock Springs Capital Management sold out of CONMED (CNMD) in Q3 2023, closing a stake of 205,000 shares — an estimated $27.9M sold.

Rock Springs Capital Management first reported a position in CNMD in Q1 2020 and held it in 14 quarters. The position peaked at $30.1M in Q1 2022. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

Rock Springs Capital Management reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
Rock Springs Capital Management sold 205,000 CONMED shares in Q3 2023, an estimated $27.9M.
Rock Springs Capital Management first reported a position in CONMED in Q1 2020 and held it in 14 quarters.
Rock Springs Capital Management's CONMED position peaked at $30.1M in Q1 2022.
275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Rock Springs Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.